CompilationResults Destiny-06 Phase 3 Clinical Study demonstrate that the conjugated antibody Trastuzumab deruxtecan (T-DXd) provides better results than traditional chemotherapy…
The goal is to control the expression of tumor genes using mRNA contained in tumor-derived extracellular vesicles. July 10, 2024,…
CompilationThe results of pancreatic cancer treatment are usually not very encouraging for the scientific community; the tumor microenvironment of these…
CompilationBehind the acronym “Unique” lies a new next-generation single-cell cross-sectional sequencing platform. Subsidized by the "la Caixa" Foundation, it will…